Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
- 1 September 1997
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 350 (9082), 911-917
- https://doi.org/10.1016/s0140-6736(97)02307-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Methotrexate pharmacokinetics and prognosis in osteosarcoma.Journal of Clinical Oncology, 1994
- A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.Journal of Clinical Oncology, 1992
- Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.Journal of Clinical Oncology, 1992
- Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's SarcomaJNCI Journal of the National Cancer Institute, 1991
- The Role of Methotrexate in OsteosarcomaJNCI Journal of the National Cancer Institute, 1988
- Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.Journal of Clinical Oncology, 1988
- Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.Journal of Clinical Oncology, 1987
- Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.Journal of Clinical Oncology, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.Journal of Clinical Oncology, 1984